Hilar cholangiocarcinoma
Conditions
Interventions
Observational group:None
Sponsors
The First Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. The first admission is more than 48 hours, and the age is 18–90 years old; 2. Summary of nutritional risk screening scores within 24 hours after admission (NRS2002); 3. Preoperative diagnosis of hilar cholangiocarcinoma through various imaging, underwent radical HCCA resection, and complete postoperative related clinical outcome data; 4. Clear clinicopathological and nutritional assessment information is required, and paraffin pathology is clearly diagnosed as bile duct adenocarcinoma; 5. No distant metastatic lesions were found before and during surgery; 6. Did not receive any neoadjuvant chemotherapy, radiotherapy and immunotherapy before surgery.
Exclusion criteria
Exclusion criteria: 1. Postoperative hospital stay <= 7 days; 2. The patient is pregnant or breastfeeding; 3. Paraffin pathology was clearly diagnosed as other tumors (including lower bile duct cancer, ampullary cancer, gallbladder cancer, intrahepatic bile duct cancer); 4. Combined malignant tumors that are incurable in other systems; 5. The preoperative diagnosis is that acute infectious diseases have not been cured; 6. There is an aggravation period of severe blood, kidney, cardiovascular and cerebrovascular diseases; 7. Clearly diagnosed as an autoimmune disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General demographic data (gender, age, height, weight, etc.);Nutrition-related indicators (BMI, dietary intake, degree of weight loss prior to hospitalization, past medical history, etc.);Hospitalization-related data (length of hospital stay, discharge date, number of hospitalizations, history of previous hepatobiliary or pancreatic surgery, past medical history, total hospitalization costs, nursing fees, medical service fees, duration of monitoring in intensive care unit);Biochemical indicators (duration of jaundice, albumin, hemoglobin, C-reactive protein, procalcitonin, CA19-9, alanine aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, total bilirubin);Surgical-related indicators (disease diagnosis, surgical procedure name, surgical approach, date of surgery, operative duration, intraoperative blood loss, tumor differentiation grade, TNM staging, duration of postoperative nasogastric tube placement, presence or absence of postoperative infectious complications, duration of postoperative antibiotic use);Whether readmission occurred; | — |
Countries
China
Contacts
Public ContactWu Ying
The First Affiliated Hospital of the Army Medical University
Outcome results
None listed